Latest News
Dexcom launches Dexcom Flex CGM system for Type 2 diabetes patients in Germany
18 May 2026 - Biosensing technology company DexCom Inc (Nasdaq: DXCM) announced on Monday that it has introduced Dexcom Flex, a new continuous glucose monitoring system designed for adults with Type 2 diabetes who are not on intensive insulin therapy...
ImmunityBio secures US patent portfolio covering ANKTIVA combination therapy through to 2035
18 May 2026 - Biotechnology company ImmunityBio Inc (NASDAQ: IBRX) announced on Monday the issuance of five US patents covering the combination of its IL-15 receptor agonist ANKTIVA with Bacillus Calmette-Guérin (BCG) for the treatment of non-...
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
18 May 2026 - Endospan, a pioneer in endovascular solutions for complex aortic pathologies, announced on Monday that it has been acquired by medical device company Artivion Inc (NYSE: AORT) following US Food and Drug Administration premarket approval...
AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension
18 May 2026 - Biopharmaceutical company AstraZeneca plc (LSE: AZN) (STO: AZN) (NYSE: AZN) reported on Monday that it has received US Food and Drug Administration approval for Baxfendy (baxdrostat), the first and only aldosterone synthase inhibitor fo...
CelLBxHealth partners with AdventHealth on cancer monitoring studies
18 May 2026 - CTC intelligence company CelLBxHealth plc (AIM: CLBX) announced on Monday that it has entered a collaboration with AdventHealth, a US-based faith-based health system, to use its Parsortix platform in two clinical studies focused on mini...